ACTRN12611000306910尚未招募2 期
Phase II trial to study the efficacy of seasonal influenza vaccine in cancer patients undergoing chemotherapy
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Prevention
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Subjects > 18yrs with histologically/cytologically confirmed neoplasm starting chemotherapy or already on chemotherapy.
排除标准
- •1. Prior immunization with SIV in the current season
- •2. Known sensitivity to Influenza vaccine, eggs,
- •antibiotics - neomycin or polymyxin.
- •3. History of Guillain-Barre Syndrome
- •4. Fever (greater than 38.5 degrees Celsius) at time of
- •administration of Fluvax
研究者
相似试验
进行中（未招募）
1 期
Evaluate the efficacy of 12-month neoadjuvant chemotherapy in terms ofdisease-free survival in patients with localized digestive neuroendocrinecarcinomasocalized digestive Neuroendocrine CarcinomasMedDRA version: 21.0Level: LLTClassification code: 10062476Term: Neuroendocrine tumor Class: 10029104CTIS2024-515603-19-00Association Gercor78
进行中（未招募）
1 期
Clinical trial to evaluate the effectiveness and safety of acetazolamide in the treatment of cerebellar syndrome in patients with phosphomannomutase deficiency.Cerebellar syndromeMedDRA version: 19.1Level: PTClassification code 10008072Term: Cerebellar syndromeSystem Organ Class: 10029205 - Nervous system disordersEUCTR2017-000810-44-ESFundació Sant Joan de Déu30
招募中
不适用
Phase II clinical trial for the effectiveness and safety of AW-PD01 (helium / oxygen mixed gas) for respiratory failure in children and infants with airway stenotic lesions: Single facility single group open label intervention studyRespiratory failure, BronchiolitisJPRN-UMIN000025065Tokyo Metropolitan Children's Medical Center10
进行中（未招募）
1 期
Treatment of advanced adenocarcinoma of the lungAdult patients with either firstly diagnosed or relapsed advanced adenocarcinoma of the lung harbouring ROS1 translocationMedDRA version: 17.1Level: LLTClassification code 10025032Term: Lung adenocarcinoma NOSSystem Organ Class: 100000004864EUCTR2013-002737-38-ATniversity of Cologne30
进行中（未招募）
1 期
Treatment of advanced lung cancerEUCTR2018-000399-13-DEniversity of Cologne50